In breast cancer, for example, the delivery of miR-200c-3p using tumor-targeted nanoparticles has shown promise in inhibiting tumor growth and metastasis by downregulating oncogenes like ZEB1 and ZEB2 [73]. Here, ZEB1 is linked to breast carcinoma.